A new method to measure plasma levels of activated protein C in complex with protein C inhibitor in patients with acute coronary syndromes Strandberg, K.; Bhiladvala, P.; Holm, J.; More Strandberg, K.; Bhiladvala, P.; Holm, J.; Stenflo, J. Less Blood Coagulation & Fibrinolysis. 12(7):503-510, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia Gerotziafas, G. T.; Elalamy, I.; Lecrubier, C.; More Gerotziafas, G. T.; Elalamy, I.; Lecrubier, C.; Lebrazi, J.; Mirshahi, M.; Potevin, F.; Lecompte, T.; Samama, M. M. Less Blood Coagulation & Fibrinolysis. 12(7):511-520, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model Guerrero, B.; Arocha-Piñango, C. L.; Pinto, M Alves; More Guerrero, B.; Arocha-Piñango, C. L.; Pinto, M Alves; MĂ¼ller, C. A.; Juan, A. Gil San; Amorim, S.; Perales, J. Less Blood Coagulation & Fibrinolysis. 12(7):521-529, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease Wang, Z. Y.; Shi, J. M.; Han, Y.; More Wang, Z. Y.; Shi, J. M.; Han, Y.; Wang, Y. C.; Ruan, C. G. Less Blood Coagulation & Fibrinolysis. 12(7):531-537, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease Tacke, F.; Schöffski, P.; Trautwein, C.; More Tacke, F.; Schöffski, P.; Trautwein, C.; Manns, M. P.; Ganser, A.; von Depka, M. Less Blood Coagulation & Fibrinolysis. 12(7):539-545, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Idiopathic osteonecrosis in an adult with familial protein S deficiency and hyperhomocysteinemia Elishkewich, K.; Kaspi, D.; Shapira, I.; More Elishkewich, K.; Kaspi, D.; Shapira, I.; Meites, D.; Berliner, S. Less Blood Coagulation & Fibrinolysis. 12(7):547-550, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
The use of recombinant factor VIIa (NovoSeven®) in a patient with a factor XI deficiency and a circulating anticoagulant Billon, S.; Niger, C. Le; Escoffre-Barbe, M.; More Billon, S.; Niger, C. Le; Escoffre-Barbe, M.; Vicariot, M.; Abgrall, J. F. Less Blood Coagulation & Fibrinolysis. 12(7):551-553, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Thromboelastography: a reliable test? Vig, S.; Chitolie, A.; Bevan, D. H.; More Vig, S.; Chitolie, A.; Bevan, D. H.; Halliday, A.; Dormandy, J. Less Blood Coagulation & Fibrinolysis. 12(7):555-561, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Improved confirmation of weak lupus anticoagulants by employing sensitive and insensitive reagents to the lupus anticoagulant Ames, P. R. J.; Iannaccone, L.; Iasio, R. De; More Ames, P. R. J.; Iannaccone, L.; Iasio, R. De; Brancaccio, V. Less Blood Coagulation & Fibrinolysis. 12(7):563-567, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Modification of the ProC® Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation Quincampoix, J. C.; Legarff, M.; Rittling, C.; More Quincampoix, J. C.; Legarff, M.; Rittling, C.; Andiva, S.; Toulon, P. Less Blood Coagulation & Fibrinolysis. 12(7):569-576, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Comparison of three methods for measuring PEG-hirudin in blood Hoffmann, J. J. M. L.; Janssen, W. C. M. Hoffmann, J. J. M. L.; Janssen, W. C. M. Less Blood Coagulation & Fibrinolysis. 12(7):577-581, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants Kemme, M. J. B.; Faaij, R. A.; Schoemaker, R. C.; More Kemme, M. J. B.; Faaij, R. A.; Schoemaker, R. C.; Kluft, C.; Meijer, P.; Cohen, A. F.; Burggraaf, J. Less Blood Coagulation & Fibrinolysis. 12(7):583-591, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Prevalence of antithrombin deficiency in patients with chronic leg ulcer Pereira de Godoy, J. M.; Andrade Torres, C. A.; Braile, D. M. Pereira de Godoy, J. M.; Andrade Torres, C. A.; Braile, D. M. Less Blood Coagulation & Fibrinolysis. 12(7):593-595, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin Schwarz, T.; Schmidt, B.; Beyer, J.; More Schwarz, T.; Schmidt, B.; Beyer, J.; Schellong, S. M. Less Blood Coagulation & Fibrinolysis. 12(7):597-599, October 2001. Abstract Abstract Favorites PDF Get Content & Permissions Buy
O-1 The effect of methylene blue treatment on fibrinogen Less Blood Coagulation & Fibrinolysis. 12(7):A1, October 2001. Favorites Get Content & Permissions Buy
O-2 Tissue plasminogen activator antigen and coronary heart disease: new prospective study and meta-analyses. Less Blood Coagulation & Fibrinolysis. 12(7):A1-A2, October 2001. Favorites Get Content & Permissions Buy
O-3 Induction of both tissue factor expression in monocytes by lipoprotein-complexed C reactive protein: a possible mechanism underlying the adverse outcome predicted by waveform analysis Less Blood Coagulation & Fibrinolysis. 12(7):A2, October 2001. Favorites Get Content & Permissions Buy
O-4 False negative compression ultrasound in patients with suspected DVT and elevated D-dimers Less Blood Coagulation & Fibrinolysis. 12(7):A2, October 2001. Favorites Get Content & Permissions Buy
O-5 Correction of abnormal thrombin generation in FVIII deficient plasma by low concentrations of FVIII Less Blood Coagulation & Fibrinolysis. 12(7):A3, October 2001. Favorites Get Content & Permissions Buy
O-6 Inhibitory vWF-cleaving protease activity may predict clinical response in acute thrombotic thrombocytopenic purpura Less Blood Coagulation & Fibrinolysis. 12(7):A3-A4, October 2001. Favorites Get Content & Permissions Buy
O-7 Eleven year single centre experience of liver transplantation for end stage liver disease in haemophilic patients Less Blood Coagulation & Fibrinolysis. 12(7):A4, October 2001. Favorites Get Content & Permissions Buy
O-8 Immune tolerance therapy for factor VIII auto-antibodies. A single centre experience Less Blood Coagulation & Fibrinolysis. 12(7):A4-A5, October 2001. Favorites Get Content & Permissions Buy
O-9 The relationship between plasma concentration of alpha 2 macroglobulin and ABO blood group Less Blood Coagulation & Fibrinolysis. 12(7):A5, October 2001. Favorites Get Content & Permissions Buy
O-10 A chromogenic substrate assay for high molecular weight kininogen: evaluation and use for the measurement of high molecular weight kininogen levels in cardiopulmonary patients Less Blood Coagulation & Fibrinolysis. 12(7):A5-A6, October 2001. Favorites Get Content & Permissions Buy
O-11 A type 2 von willebrand disease family with an unusual phenotype and ARG 1315 CYS mutation: type 2A or type 2M? Less Blood Coagulation & Fibrinolysis. 12(7):A6, October 2001. Favorites Get Content & Permissions Buy
O-12 Recombinant factor VIIa activates platelets in whole blood Less Blood Coagulation & Fibrinolysis. 12(7):A6-A7, October 2001. Favorites Get Content & Permissions Buy
O-13 Clinical signficance of beta2-glycoprotein I polymorphisms VAL247LEU and TRP316SER in an antiphospholipid syndrome (aps) population Less Blood Coagulation & Fibrinolysis. 12(7):A7, October 2001. Favorites Get Content & Permissions Buy
O-14 A study of monocyte tissue factor expression, platelet-leucocyte conjugates, platelet and endothelial activation in patients with non-rheumatic persistent atrial fibrillation Less Blood Coagulation & Fibrinolysis. 12(7):A7-A8, October 2001. Favorites Get Content & Permissions Buy
O-15 Aspirin inhibition of arachidonic acid mediated platelet aggregation is significantly reduced during surgery Less Blood Coagulation & Fibrinolysis. 12(7):A8, October 2001. Favorites Get Content & Permissions Buy
O-16 Influence of flow on inhibition of platelet dependent thrombin generation by anti-GPIIb/IIIa and GPIbα antibodies Less Blood Coagulation & Fibrinolysis. 12(7):A8-A9, October 2001. Favorites Get Content & Permissions Buy
O-17 Lysis of fibrin by polymorphonuclear cells from septic patients Less Blood Coagulation & Fibrinolysis. 12(7):A9, October 2001. Favorites Get Content & Permissions Buy
O-18 Oxidized low density lipoprotein increases procoagulant status of atherosclerotic lesion via intrinsic pathway of blood coagulation Less Blood Coagulation & Fibrinolysis. 12(7):A9-A10, October 2001. Favorites Get Content & Permissions Buy
O-19 Molecular modelling of mutations in human factor X Less Blood Coagulation & Fibrinolysis. 12(7):A10, October 2001. Favorites Get Content & Permissions Buy
O-20 In vitro and in vivo consequences of the sepsis effect on the endothelial cell protein C receptor Less Blood Coagulation & Fibrinolysis. 12(7):A10-A11, October 2001. Favorites Get Content & Permissions Buy
P-1 A novel mutation in factor X: isoleucine 411 phenylalanine resulting in a bleeding tendency associated with low factor X protein and activity levels Less Blood Coagulation & Fibrinolysis. 12(7):A11-A12, October 2001. Favorites Get Content & Permissions Buy
P-2 Intracranial haemorrhage in a tertiary paediatric centre: a survey of 100 children with severe haemophilia Less Blood Coagulation & Fibrinolysis. 12(7):A12, October 2001. Favorites Get Content & Permissions Buy
P-3 A new candidate type 2M Von Willebrand disease mutation in an asymptomatic patient with absent ristocetin but normal botrocetin activity and a daughter with type 3 VWD Less Blood Coagulation & Fibrinolysis. 12(7):A12-A13, October 2001. Favorites Get Content & Permissions Buy
P-4 Evaluation of the PFA-100 R as a potential screening tool for platelet dysfunction Less Blood Coagulation & Fibrinolysis. 12(7):A13, October 2001. Favorites Get Content & Permissions Buy
P-5 An evaluation of genetic analysis in the diagnosis of type 2A, 2B and 2M von Willebrand disease Less Blood Coagulation & Fibrinolysis. 12(7):A13-A14, October 2001. Favorites Get Content & Permissions Buy
P-6 Optimising approaches and techniques for the provision of a comprehensive carrier and antenatal diagnostic service for haemophilias A and B Less Blood Coagulation & Fibrinolysis. 12(7):A14, October 2001. Favorites Get Content & Permissions Buy
P-7 Use of recombinant factor VIIa in platelet disorders – a single centre experience Less Blood Coagulation & Fibrinolysis. 12(7):A14-A15, October 2001. Favorites Get Content & Permissions Buy
P-8 Anticardiolipin antibodies and pregnancy outcome: a prospective study in an unselected obstetric population Less Blood Coagulation & Fibrinolysis. 12(7):A15, October 2001. Favorites Get Content & Permissions Buy
P-9 Characterisation of a commercial EIA for plasma homocysteine Less Blood Coagulation & Fibrinolysis. 12(7):A15-A16, October 2001. Favorites Get Content & Permissions Buy
P-10 Haemostatic and inflammatory variables and prevalent cardiovascular disease: British regional heart study Less Blood Coagulation & Fibrinolysis. 12(7):A16, October 2001. Favorites Get Content & Permissions Buy
P-11 Audit of usefulness of β2GP1 in the assessment of the antiphospholipid syndrome. Less Blood Coagulation & Fibrinolysis. 12(7):A16-A17, October 2001. Favorites Get Content & Permissions Buy
P-12 The GLN27GLU beta-2 adrenoreceptor polymorphism is associated with elevation of FVIII:C and venous thromboembolism Less Blood Coagulation & Fibrinolysis. 12(7):A17, October 2001. Favorites Get Content & Permissions Buy
P-13 Detection of factor V Leiden and prothrombin G22210A in whole blood using the lightcycler system TM Less Blood Coagulation & Fibrinolysis. 12(7):A17-A18, October 2001. Favorites Get Content & Permissions Buy
P-14 Tissue factor independent PCA of T lymphoblastoid cell lines: relationship to stage of differentiation. Less Blood Coagulation & Fibrinolysis. 12(7):A18, October 2001. Favorites Get Content & Permissions Buy
P-15 Thromboelastography in general haemostasis in Southampton University Hospitals Less Blood Coagulation & Fibrinolysis. 12(7):A18-A19, October 2001. Favorites Get Content & Permissions Buy
P-16 Sigma AMAX 190 coagulometer: evaluation and performance characteristics for use in a routine clinical laboratory. Less Blood Coagulation & Fibrinolysis. 12(7):A19, October 2001. Favorites Get Content & Permissions Buy
P-17 Evaluation of Sysmex CA50 for routine use Less Blood Coagulation & Fibrinolysis. 12(7):A19-A20, October 2001. Favorites Get Content & Permissions Buy
P-18 Successful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity plasma derived factor VIII concentrate BPL 8Y Less Blood Coagulation & Fibrinolysis. 12(7):A20, October 2001. Favorites Get Content & Permissions Buy
P-19 A systematic review of outcome measures used to define oral anticoagulation therapeutic control Less Blood Coagulation & Fibrinolysis. 12(7):A20-A21, October 2001. Favorites Get Content & Permissions Buy
P-20 Demonstration of the sensitivity of thromboelastography for detecting the presence of heparins and heparinoids Less Blood Coagulation & Fibrinolysis. 12(7):A21, October 2001. Favorites Get Content & Permissions Buy
P-21 The therapeutic potential of Desmopressin in Ehlers Danlos Syndrome: a case report Less Blood Coagulation & Fibrinolysis. 12(7):A21-A22, October 2001. Favorites Get Content & Permissions Buy
P-22 Response to anti-viral therapy for chronic hepatitis C infection in patients with haemophilia and von Willebrand's disease: correlation with serum hyaluronic acid levels Less Blood Coagulation & Fibrinolysis. 12(7):A22, October 2001. Favorites Get Content & Permissions Buy
P-23 Inhibitor formation in a patient with inherited factor XI deficiency Less Blood Coagulation & Fibrinolysis. 12(7):A22-A23, October 2001. Favorites Get Content & Permissions Buy
P-24 An unusual type 2A von Willebrand disease phenotype with associated thrombocytopaenia Less Blood Coagulation & Fibrinolysis. 12(7):A23, October 2001. Favorites Get Content & Permissions Buy
P-25 Inverse relationship between plasma von Willebrand factor and soluble P-selectin in patients with type 1 but not type 2 von Willebrand disease Less Blood Coagulation & Fibrinolysis. 12(7):A23-A24, October 2001. Favorites Get Content & Permissions Buy
P-26 Ristocetin cofactor activity remains an essential test in von Willebrand disease screen for type 1 individuals Less Blood Coagulation & Fibrinolysis. 12(7):A24, October 2001. Favorites Get Content & Permissions Buy
P-27 Detection of D-dimers in cerebral spinal fluid (CSF-DD) using a routine D-dimer assay: exclusion of sub-arachnoid haemorrage and meningitis Less Blood Coagulation & Fibrinolysis. 12(7):A24-A25, October 2001. Favorites Get Content & Permissions Buy
P-28 Early identification of the risk of mortality, the development of disseminated intravascular coagulation (DIC) and the diagnosis of sepsis through waveform analysis in a simple assay of coagulation Less Blood Coagulation & Fibrinolysis. 12(7):A25, October 2001. Favorites Get Content & Permissions Buy
P-29 Alternatives for the provision of a regional anticoagulation service: Goodbye Yellow Book Road! Less Blood Coagulation & Fibrinolysis. 12(7):A25-A26, October 2001. Favorites Get Content & Permissions Buy
P-30 The local formulation of a protocol for the administration of intravenous heparin to improve medical compliance and patient therapeutic control Less Blood Coagulation & Fibrinolysis. 12(7):A26, October 2001. Favorites Get Content & Permissions Buy
P-31 A child with a positive lupus anticoagulant who underwent repair of a ventricular septal defect Less Blood Coagulation & Fibrinolysis. 12(7):A26-A27, October 2001. Favorites Get Content & Permissions Buy
P-32 Reference ranges for fibrin D-dimer and other haemostatic/inflammatory variables in men aged 60–79 years: implications for diagnosis of venous thromboembolism, inflammation and bleeding disorders Less Blood Coagulation & Fibrinolysis. 12(7):A27, October 2001. Favorites Get Content & Permissions Buy
P-33 Physical activity and haemostatic and inflammatory variables in older men Less Blood Coagulation & Fibrinolysis. 12(7):A27-A28, October 2001. Favorites Get Content & Permissions Buy
P-34 Acquired activated protein C resistance in antiphospholipid patients is independent of IgG β 2 -glycoprotein-I antibodies Less Blood Coagulation & Fibrinolysis. 12(7):A28, October 2001. Favorites Get Content & Permissions Buy
P-35 The pharmacokinetics of Ximelagatran following single and repeated oral dosing to healthy male subjects Less Blood Coagulation & Fibrinolysis. 12(7):A28-A29, October 2001. Favorites Get Content & Permissions Buy
P-36 Inter-laboratory variation in antiphospholipid antibody testing Less Blood Coagulation & Fibrinolysis. 12(7):A29, October 2001. Favorites Get Content & Permissions Buy
P-37 Does factor XII have a role in fetal development? Less Blood Coagulation & Fibrinolysis. 12(7):A29-A30, October 2001. Favorites Get Content & Permissions Buy
P-38 D-dimers of > 1,000 in patients with proven DVT are suggestive of cancer Less Blood Coagulation & Fibrinolysis. 12(7):A30, October 2001. Favorites Get Content & Permissions Buy
P-39 Interleukin-6 as a predictor of coronary heart disease Less Blood Coagulation & Fibrinolysis. 12(7):A30-A31, October 2001. Favorites Get Content & Permissions Buy
P-40 Are supranormal factor VII levels a risk factor for pregnancy related venous thromboembolic disease Less Blood Coagulation & Fibrinolysis. 12(7):A31, October 2001. Favorites Get Content & Permissions Buy
